These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 9920903)

  • 41. Involvement of the Oct-1 regulatory element of the gadd45 promoter in the p53-independent response to ultraviolet irradiation.
    Takahashi S; Saito S; Ohtani N; Sakai T
    Cancer Res; 2001 Feb; 61(3):1187-95. PubMed ID: 11221850
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Activation of the p21(Waf1/Cip1) promoter by the ets oncogene family transcription factor E1AF.
    Funaoka K; Shindoh M; Yoshida K; Hanzawa M; Hida K; Nishikata S; Totsuka Y; Fujinaga K
    Biochem Biophys Res Commun; 1997 Jul; 236(1):79-82. PubMed ID: 9223430
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Human homologue of yeast Rad23 protein A interacts with p300/cyclic AMP-responsive element binding (CREB)-binding protein to down-regulate transcriptional activity of p53.
    Zhu Q; Wani G; Wani MA; Wani AA
    Cancer Res; 2001 Jan; 61(1):64-70. PubMed ID: 11196199
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A polymorphic microsatellite that mediates induction of PIG3 by p53.
    Contente A; Dittmer A; Koch MC; Roth J; Dobbelstein M
    Nat Genet; 2002 Mar; 30(3):315-20. PubMed ID: 11919562
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Wild-type p53 mediates positive regulation of gene expression through a specific DNA sequence element.
    Zambetti GP; Bargonetti J; Walker K; Prives C; Levine AJ
    Genes Dev; 1992 Jul; 6(7):1143-52. PubMed ID: 1628822
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cloning and characterization of the promoter region of human focal adhesion kinase gene: nuclear factor kappa B and p53 binding sites.
    Golubovskaya V; Kaur A; Cance W
    Biochim Biophys Acta; 2004 May; 1678(2-3):111-25. PubMed ID: 15157737
    [TBL] [Abstract][Full Text] [Related]  

  • 47. c-Jun transactivates the promoter of the human p21(WAF1/Cip1) gene by acting as a superactivator of the ubiquitous transcription factor Sp1.
    Kardassis D; Papakosta P; Pardali K; Moustakas A
    J Biol Chem; 1999 Oct; 274(41):29572-81. PubMed ID: 10506225
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Two functionally divergent p53-responsive elements in the rat bradykinin B2 receptor promoter.
    Marks J; Saifudeen Z; Dipp S; El-Dahr SS
    J Biol Chem; 2003 Sep; 278(36):34158-66. PubMed ID: 12791684
    [TBL] [Abstract][Full Text] [Related]  

  • 49. UV-B/A irradiation of mouse keratinocytes results in p53-mediated WAF1/CIP1 expression.
    Liu M; Pelling JC
    Oncogene; 1995 May; 10(10):1955-60. PubMed ID: 7761096
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The c-fos proto-oncogene is a target for transactivation by the p53 tumor suppressor.
    Elkeles A; Juven-Gershon T; Israeli D; Wilder S; Zalcenstein A; Oren M
    Mol Cell Biol; 1999 Apr; 19(4):2594-600. PubMed ID: 10082525
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Modulation of cellular and viral promoters by mutant human p53 proteins found in tumor cells.
    Deb S; Jackson CT; Subler MA; Martin DW
    J Virol; 1992 Oct; 66(10):6164-70. PubMed ID: 1356162
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Transcriptional repression of p21(waf1) promoter by hepatitis B virus X protein via a p53-independent pathway.
    Ahn JY; Chung EY; Kwun HJ; Jang KL
    Gene; 2001 Sep; 275(1):163-8. PubMed ID: 11574165
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Functional p53 protein in human papillomavirus-positive cancer cells.
    Butz K; Shahabeddin L; Geisen C; Spitkovsky D; Ullmann A; Hoppe-Seyler F
    Oncogene; 1995 Mar; 10(5):927-36. PubMed ID: 7898934
    [TBL] [Abstract][Full Text] [Related]  

  • 54. SW480, a p53 double-mutant cell line retains proficiency for some p53 functions.
    Rochette PJ; Bastien N; Lavoie J; Guérin SL; Drouin R
    J Mol Biol; 2005 Sep; 352(1):44-57. PubMed ID: 16061257
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Targets for transcriptional activation by wild-type p53: endogenous retroviral LTR, immunoglobulin-like promoter, and an internal promoter of the mdm2 gene.
    Barak Y; Lupo A; Zauberman A; Juven T; Aloni-Grinstein R; Gottlieb E; Rotter V; Oren M
    Cold Spring Harb Symp Quant Biol; 1994; 59():225-35. PubMed ID: 7587074
    [No Abstract]   [Full Text] [Related]  

  • 56. Transcriptional activation of p21(waf1/cip1) by alkylphospholipids: role of the mitogen-activated protein kinase pathway in the transactivation of the human p21(waf1/cip1) promoter by Sp1.
    De Siervi A; Marinissen M; Diggs J; Wang XF; Pages G; Senderowicz A
    Cancer Res; 2004 Jan; 64(2):743-50. PubMed ID: 14744793
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Dominance of wild-type p53-mediated transcriptional activation in breast epithelial cells.
    Davis P; Bazar K; Huper G; Lozano G; Marks J; Iglehart JD
    Oncogene; 1996 Sep; 13(6):1315-22. PubMed ID: 8808706
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Insights into selective activation of p53 DNA binding by c-Abl.
    Wei G; Li AG; Liu X
    J Biol Chem; 2005 Apr; 280(13):12271-8. PubMed ID: 15661746
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Wild-type p53 controls cell motility and invasion by dual regulation of MET expression.
    Hwang CI; Matoso A; Corney DC; Flesken-Nikitin A; Körner S; Wang W; Boccaccio C; Thorgeirsson SS; Comoglio PM; Hermeking H; Nikitin AY
    Proc Natl Acad Sci U S A; 2011 Aug; 108(34):14240-5. PubMed ID: 21831840
    [TBL] [Abstract][Full Text] [Related]  

  • 60. WT1-p53 interactions in insulin-like growth factor-I receptor gene regulation.
    Idelman G; Glaser T; Roberts CT; Werner H
    J Biol Chem; 2003 Jan; 278(5):3474-82. PubMed ID: 12444079
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.